CLINICAL_TRIALS
trial_result
· 2022-03-07
Clinical Trial Update: Efficacy and Safety of Saturno IIB Association on the Control of Ocular Inflammation Post-phacoemulsification [Phase 2]
Summary
A Phase 2 trial update reports efficacy and safety of Saturno IIB association for controlling ocular inflammation after cataract surgery.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: EMS | Conditions: Ocular Inflammation, Cataract | Phase 2 | Status: COMPLETED